29207 SHIRE-UK-AS - Takeda Pharmaceuticals U.S.A., Inc., US
Adjacency: 3 Upstream: 3 Downstream: 0
Upstream Adjacent AS list
AS46887 CROWNCASTLE-AS46887 - Crown Castle Fiber LLC, US
AS13237 LAMBDANET-AS - euNetworks GmbH, DE
AS701 UUNET - Verizon Business, US
Rank AS Type Originate Addr Space (pfx) Transit Addr space (pfx) Description 35509 AS29207 ORIGIN Originate: 1024 /22.00 Transit: 0 /0.00 SHIRE-UK-AS - Takeda Pharmaceuticals U.S.A., Inc., US
Aggregation Suggestions
Filter: Aggregates, Specifics
This report does not take into account conditions local to each origin AS in terms of policy or traffic engineering requirements, so this is an approximate guideline as to aggregation possibilities.
Rank AS AS Name Current Wthdw Aggte Annce Redctn % 38427 AS29207 SHIRE-UK-AS - Takeda Pharmaceuticals U.S.A., 4 0 0 4 0 0.00% Prefix AS Path Aggregation Suggestion 43.229.159.0/24 4777 2516 3257 13237 29207 67.131.130.0/24 4777 2516 701 29207 195.216.225.0/24 4777 2516 701 29207 198.102.213.0/24 4777 2516 1299 46887 29207
Advertisements that are fragments of the original RIR allocation (more specifics) originated by this AS.
AS29207 2 More Specifics 4 Total Advertisements SHIRE-UK-AS - Takeda Pharmaceuticals U.S.A., Inc., US
43.229.159.0/24 43.229.156.0/22
67.131.130.0/24 67.128.0.0/13
whois: 402603
IANA has recorded AS29207 as originally allocated by
/usr/bin/whois -h jwhois.apnic.netr "AS29207\n % This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html
% Note: this output has been filtered.
% Information related to 'AS29092 - AS29337'
as-block: AS29092 - AS29337
descr: RIPE NCC ASN block
remarks: These AS Numbers are assigned to network operators in the RIPE NCC service region.
mnt-by: RIPE-NCC-HM-MNT
created: 2018-11-22T15:27:31Z
last-modified: 2018-11-22T15:27:31Z
source: RIPE
% Information related to 'AS29207'
% Abuse contact for 'AS29207' is 'jim.richards@takeda.com'
aut-num: AS29207
as-name: SHIRE-UK-AS
org: ORG-SPL13-RIPE
import: from AS5089 action pref=100; accept ANY
import: from AS1239 action pref=100; accept ANY
import: from AS6939 action pref=100; accept ANY
export: to AS5089 announce AS29207
export: to AS1239 announce AS29207
export: to AS6939 announce AS29207
default: to AS1239 action pref=100; networks ANY
admin-c: TA9588-RIPE
tech-c: TA9588-RIPE
status: ASSIGNED
mnt-by: RIPE-NCC-END-MNT
mnt-by: SHIRE-MNT
remarks: mnt-by: SHIRE-MNT
remarks: mnt-routes: SHIRE-MNT
created: 2003-07-01T07:56:33Z
last-modified: 2025-10-16T10:26:45Z
source: RIPE # Filtered
organisation: ORG-SPL13-RIPE
org-name: Takeda Pharmaceuticals U.S.A., Inc.
country: US
reg-nr: 2894153 (Delaware)
org-type: LIR
address: 95 Hayden Avenue
address: MA 02421
address: Lexington
address: UNITED STATES
phone: +1-630-835-8017
phone: +17814829222
abuse-c: AC31348-RIPE
mnt-by: SHIRE-MNT
mnt-ref: SHIRE-MNT
mnt-ref: RIPE-NCC-HM-MNT
mnt-by: RIPE-NCC-HM-MNT
created: 2013-12-11T09:35:52Z
last-modified: 2026-05-13T07:15:50Z
source: RIPE # Filtered
%ERROR:201: access denied for 2401:2000:6660:0:0:0:0:13
%
% Queries from your IP address have passed the daily limit of controlled objects.
% Access from your host has been temporarily denied.
% For more information, see
% https://docs.db.ripe.net/FAQ#why-did-i-receive-an-error-201-access-denied
% This query was served by the RIPE Database Query Service version 1.122.1 (SHETLAND)